SCHEMBL932111

SCHEMBL932111

CC1=NC(c2cccc(Br)c2)(c2cc(C)nc(C)c2)N=C1N

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 17/20 0.47
BACE2 Q9Y5Z0 1/20 0.45
KCNH2 Q12809 3/20 0.42
APP P05067 3/20 0.39
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CTSD P07339 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932046 0.87 BACE1 (0.60) BACE1BACE2KCNH2APPCTSD
SCHEMBL932108 0.83 BACE1 (0.62) BACE1BACE2KCNH2APPCTSD
SCHEMBL933512 0.82 BACE1 (0.63) BACE1BACE2KCNH2APPCTSD
SCHEMBL932204 0.82 BACE1 (0.67) BACE1BACE2KCNH2APP
SCHEMBL932757 0.80 BACE1 (0.44) BACE1BACE2KCNH2APPALDH1A1
SCHEMBL932706 0.80 BACE1 (0.66) BACE1BACE2KCNH2APPRXFP1
SCHEMBL932503 0.78 BACE1 (0.67) BACE1BACE2KCNH2CTSD
SCHEMBL932175 0.78 BACE1 (0.51) BACE1BACE2KCNH2APPCTSD
SCHEMBL946979 0.77 BACE1 (0.42) BACE1BACE2KCNH2APPMEN1
SCHEMBL933023 0.77 BACE1 (0.75) BACE1BACE2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed